FutuRx
- Liana Patt
Dr. Liana Patt, Chief Executive Officer at FutuRx is a healthcare executive with over 20 years in pharma & biotech.
Liana brings specific expertise in innovation evaluation, strategic development, fund raising for a wide range of technologies and therapeutic areas, through extensive value creation in NewCos establishment, development and commercialization.
Before joining FutuRx Liana was the CEO of Integra Holdings, the Healthcare VC arm of the Hebrew university since 2013.
Prior to that, Liana served as VP Search & Evaluation and Business Development at TEVA where she led global teams responsible for investments and in-licensing.
She holds a PhD from the WIS and an MBA from Edinburgh Business School.
Org chart
Upgrade to view 6 reports
Offices
This person is not in any offices
FutuRx
FutuRx is a biotech incubator founded by three leading global healthcare players. FutuRx leverages its access to the Israeli biotech industry, and to leading research institutes in Israel and worldwide, to identify and develop highly innovative technologies. Experts at Takeda, J&J, and OrbiMed are deeply involved in the project selection process and during the incubator period of each company. The result is a clear impact on the efficient translation of innovative research to clinically meaningful products.
